ArticleHaematologica2025

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.

Carlos Jiménez-Vicente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.